Skip to main content
. 2018 Apr 20;10(4):678–691. doi: 10.1080/19420862.2018.1452580

Figure 3.

Figure 3.

Higher Order Structure: Comparison of ABP 215, Bevacizumab (US), and Bevacizumab (EU) Fourier-transform infrared spectra (a), ultraviolet circular dichroism spectra (b), and differential scanning calorimetry thermograms (c).